Discontinuation report MYOCHRYSINE

Last updated on 2019-06-10 History
Report ID 86067
Drug Identification Number 01927620
Brand name MYOCHRYSINE
Common or Proper name Myochrysine 10 mg
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) GOLD SODIUM THIOMALATE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5 ampoules
ATC code M01CB
ATC description SPECIFIC ANTIRHEUMATIC AGENTS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2019-06-04
Remaining supply date 2018-04-04
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments The continued global shortage of Myochrysine is due to manufacturing issues with the active ingredient. Consequently Sanofi has decided to discontinue all three strengths of Myochrysine globally.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-06-10 French Compare
v1 2019-06-10 English Compare